Require a new FDA 5-year Action Plan.

Mike Quigley · Illinois · Democratic

oversight impact 2.00 specificity 1.00 extraction confidence 95%

Commitment kind: unknown. Promised action: not established. Promised outcome: not established. Deadline: unknown; not assumed expired.

Contest this claim

Occurrences

Evidence

legacy_unverified · Source version not recorded · locator unknown

The bill text shows Rep. Mike Quigley introduced H.R. 8205 with Rep. Calvert. Section 4 would require the FDA Commissioner to publish a report containing an updated action plan describing FDA actions during the 5-year period after publication.

Unverified model/legacy excerpt; not proof. AI summary (separate from source): Quigley took concrete legislative action toward the commitment by introducing H.R. 8205, which contains language for a new or updated FDA rare neurodegenerative disease action plan covering a five-year period.

partial same_term A for effort

U.S. House Committee Repository: H.R. 8205, Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026
secondary · model gpt-5.5 · confidence 90%

Contest this evidence item

legacy_unverified · Source version not recorded · locator unknown

GovInfo lists H.R. 8205 as placed on the Senate calendar on July 23, 2026, with the action: received, read twice and placed on the calendar. The record does not show enactment as public law.

Unverified model/legacy excerpt; not proof. AI summary (separate from source): The latest official status found after checking the Aug. 12-14 lookback is still pending in the Senate, so the FDA action-plan requirement has not been finally delivered, though the House-passed bill represents substantial progress.

partial same_term A for effort

H.R. 8205 (PCS) - Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026
secondary · model gpt-5.5 · confidence 88%

Contest this evidence item

Assessments

Public state: unverified As of unknown · legacy_unverified · . Original AI recommendation (not independently established): never. unknown A for effort

Quigley materially advanced the promise by introducing H.R. 8205, which included a requirement for an updated FDA action plan covering a five-year period. However, the record provided shows the bill only reached the Senate calendar on July 23, 2026 and was not enacted as public law, so the promised requirement has not been legally delivered. This warrants credit for a serious same-term legislative attempt, but not fulfillment.

provider codex_cli · model gpt-5.5 · confidence 88%